Oppenheimer Downgrades Intercept Despite Two-Day Share Collapse By: TalkMarkets September 22, 2017 at 15:23 PM EDT Oppenheimer analyst Jay Olson downgraded this afternoon shares of Intercept Pharmaceuticals to Perform from Outperform. Read More >> Related Stocks: Intercept Pharmaceuticals